<< Back to podcast list Strategic Partner(s) Martin Audet About Dr. Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke He is the head of the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging Martin Audet on the web LinkedIn Twitter Sherbrooke University Google Scholar Dr.

Jean Martin Beaulieu About Dr. Jean Martin Beaulieu Dr. Jean Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

Explore Martin Marro’s impact on GPCR drug discovery, assay innovation, and translational pharmacology Martin Marro, currently Executive Director and Head of Cell Pharmacology at Eli Lilly’s Obesity Research About Martin Marro Dr. Martin Marro leads the Cell Pharmacology group in the Diabetes, Obesity and Complications Therapeutic

Instructors at the course included Marc Chabre , Harden McConnell , Richard Henderson , Martin Rodbell , Jean-Pierre Changeux , and Martin Karplus .

Schihada Following studies in Pharmacy in Regensburg, Germany, I joined the receptor pharmacology group of Martin

During my PhD studies in Martin Lohse lab at the Max Delbrueck Center in Berlin, I consolidated my knowledge

Martine Smit . During his Ph.D., Timo, together with Dr.

Jean Martin Beaulieu (2003) Dr. Laura Bohn (1999) Dr. Kathleen Caron - Co-host- (1970) Dr.

biased signaling is evolutionarily conserved, and why he chose a book over a review 48:09 Dinner with Martin "I'm not surprised." - Martin Rodbell, upon being shown Arey's FSH signaling data drawn on a dinner napkin

in Molecular Pharmacology at Monash University, then trained in single-cell biology as an NHMRC CJ Martin

Five scientists audit what AI can and can't do for GPCR drug discovery — from orphan receptors and biased contains the phrase "machine learning" whether they fully believe in it or not, this panel is an honest audit

that support scale ✅ Create investor-ready operating structures Our Partners Benefit From: Strategy Audits

Audit and compare CRO options based on speed, quality, and fit Clarify deliverables and oversight to

the most drugged protein family in medicine, but until recently their role in cancer was treated as marginal

chemically possible Thermostabilizing the beta-adrenergic receptor by 21 degrees Celsius was not a marginal

look at what it means to modulate opioid pharmacology downstream of the receptor — and why the safety margins